Literature DB >> 31112350

The histologic spectrum of soft tissue spindle cell tumors with NTRK3 gene rearrangements.

Albert J Suurmeijer1, Brendan C Dickson2, David Swanson2, Lei Zhang3, Yun-Shao Sung3, Hsuan-Ying Huang4, Christopher D Fletcher5, Cristina R Antonescu3.   

Abstract

NTRK3-rearranged tumors other than infantile fibrosarcomas (IFSs) harboring the canonical ETV6-NTRK3 fusions are uncommon, and include mainly inflammatory myofibroblastic tumors and gastrointestinal stromal tumors. Herein, we describe an additional subset of seven tumors sharing NTRK3 gene rearrangements. The cohort included five females and two males (age range 1-67 years). Tumors were located in extremities, trunk, retroperitoneum, or intra-abdominal. In all tumors, fluorescence in situ hybridization (FISH) revealed rearrangements in NTRK3 accompanied by NTRK3 amplification in two cases. In three cases, RNA sequencing identified a fusion transcript composed of NTRK3 exon 14 fused to ETV6, TFG, and TPM4, respectively, retaining the NTRK3 kinase domain. All tumors were positive for pan-TRK by immunohistochemistry (IHC). Two cases showed low- to intermediate-grade histology composed of monomorphic spindle cells arranged in a patternless architecture, stromal bands, and perivascular rings of hyalinized collagen and coexpression of S100 and CD34. The remaining five cases were high-grade fascicular monomorphic spindle cell sarcomas, morphologically somewhat reminiscent of either malignant peripheral nerve sheath tumors (MPNSTs) or fibrosarcomas (FSs). Two high-grade NTRK3 sarcomas showed aggressive clinical behavior with development of lung metastases. Identification of high-grade NTRK3-rearranged sarcomas is clinically important, since the development of selective NTRK inhibitors has opened new avenues for targeted therapy. Although IHC for pan-TRK can be applied as a screening tool, molecular studies are recommended for a conclusive diagnosis of NTRK-rearranged neoplasms.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  zzm321990NTRK3; fibrosarcoma; fusion; malignant peripheral nerve sheath tumor; sarcoma

Mesh:

Substances:

Year:  2019        PMID: 31112350      PMCID: PMC6733642          DOI: 10.1002/gcc.22767

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  14 in total

Review 1.  How Technology Is Improving the Multidisciplinary Care of Sarcoma.

Authors:  Inga-Marie Schaefer; Kelvin Hong; Anusha Kalbasi
Journal:  Am Soc Clin Oncol Educ Book       Date:  2020-05

Review 2.  [New in the current WHO classification (2020) for soft tissue sarcomas].

Authors:  Eva Wardelmann; Wolfgang Hartmann
Journal:  Pathologe       Date:  2021-04-06       Impact factor: 1.011

3.  NTRK -Rearranged Uterine Sarcomas: Clinicopathologic Features of 15 Cases, Literature Review, and Risk Stratification.

Authors:  Danielle C Costigan; Marisa R Nucci; Brendan C Dickson; Martin C Chang; Sharon Song; Lynette M Sholl; Jason L Hornick; Christopher D M Fletcher; David L Kolin
Journal:  Am J Surg Pathol       Date:  2022-06-20       Impact factor: 6.298

4.  Adult NTRK-rearranged spindle cell neoplasms of the viscera: with an emphasis on rare locations and heterologous elements.

Authors:  Jen-Wei Tsai; Jen-Chieh Lee; Tsung-Han Hsieh; Shih-Chiang Huang; Pei-Hang Lee; Ting-Ting Liu; Yu-Chien Kao; Ching-Di Chang; Te-Fu Weng; Chien-Feng Li; Jung-Chia Lin; Cher-Wei Liang; Yu-Li Su; Ian Yi-Feng Chang; Yu-Ting Wang; Nien-Yi Chang; Shih-Chen Yu; Jui-Chu Wang; Hsuan-Ying Huang
Journal:  Mod Pathol       Date:  2022-02-11       Impact factor: 8.209

5.  Superficial ALK-rearranged myxoid spindle cell neoplasm: a cutaneous soft tissue tumor with distinctive morphology and immunophenotypic profile.

Authors:  Steven D Billings; Jennifer S Ko; Josephine K Dermawan; Elizabeth M Azzato; John R Goldblum; Brian P Rubin
Journal:  Mod Pathol       Date:  2021-06-04       Impact factor: 7.842

6.  Unclassified low grade spindle cell sarcoma with storiform pattern characterized by recurrent novel EWSR1/FUS-NACC1 fusions.

Authors:  Cristina R Antonescu; Brendan C Dickson; Lei Zhang; Yun-Shao Sung; Christopher D Fletcher
Journal:  Mod Pathol       Date:  2021-04-15       Impact factor: 7.842

7.  Case Report: Adult NTRK-Rearranged Spindle Cell Neoplasm: Early Tumor Shrinkage in a Case With Bone and Visceral Metastases Treated With Targeted Therapy.

Authors:  Federica Recine; Alessandro De Vita; Valentina Fausti; Federica Pieri; Alberto Bongiovanni; Eugenia Franchini; Roberto Casadei; Maria Cristina Falasconi; Devil Oboldi; Federica Matteucci; Maria Caterina Pallotti; Laura Mercatali; Nada Riva; Lorena Gurrieri; Silvia Vanni; Chiara Liverani; Giacomo Miserocchi; Chiara Spadazzi; Claudia Cocchi; Toni Ibrahim
Journal:  Front Oncol       Date:  2022-01-07       Impact factor: 6.244

8.  NTRK Fusions Identified in Pediatric Tumors: The Frequency, Fusion Partners, and Clinical Outcome.

Authors:  Xiaonan Zhao; Chelsea Kotch; Elizabeth Fox; Lea F Surrey; Gerald B Wertheim; Zubair W Baloch; Fumin Lin; Vinodh Pillai; Minjie Luo; Portia A Kreiger; Jennifer E Pogoriler; Rebecca L Linn; Pierre A Russo; Mariarita Santi; Adam C Resnick; Phillip B Storm; Stephen P Hunger; Andrew J Bauer; Marilyn M Li
Journal:  JCO Precis Oncol       Date:  2021-01-14

Review 9.  Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network.

Authors:  G D Demetri; C R Antonescu; B Bjerkehagen; J V M G Bovée; K Boye; M Chacón; A P Dei Tos; J Desai; J A Fletcher; H Gelderblom; S George; A Gronchi; R L Haas; N Hindi; P Hohenberger; H Joensuu; R L Jones; I Judson; Y-K Kang; A Kawai; A J Lazar; A Le Cesne; R Maestro; R G Maki; J Martín; S Patel; F Penault-Llorca; C Premanand Raut; P Rutkowski; A Safwat; M Sbaraglia; I-M Schaefer; L Shen; C Serrano; P Schöffski; S Stacchiotti; K Sundby Hall; W D Tap; D M Thomas; J Trent; C Valverde; W T A van der Graaf; M von Mehren; A Wagner; E Wardelmann; Y Naito; J Zalcberg; J-Y Blay
Journal:  Ann Oncol       Date:  2020-09-03       Impact factor: 32.976

Review 10.  NTRK Fusions in Sarcomas: Diagnostic Challenges and Clinical Aspects.

Authors:  Vasiliki Siozopoulou; Evelien Smits; Koen De Winne; Elly Marcq; Patrick Pauwels
Journal:  Diagnostics (Basel)       Date:  2021-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.